ATE288586T1 - Detektierung neuraler aktivität - Google Patents

Detektierung neuraler aktivität

Info

Publication number
ATE288586T1
ATE288586T1 AT99955537T AT99955537T ATE288586T1 AT E288586 T1 ATE288586 T1 AT E288586T1 AT 99955537 T AT99955537 T AT 99955537T AT 99955537 T AT99955537 T AT 99955537T AT E288586 T1 ATE288586 T1 AT E288586T1
Authority
AT
Austria
Prior art keywords
neural activity
activity
detection
compound
pattern
Prior art date
Application number
AT99955537T
Other languages
English (en)
Inventor
Kim Kaiser
Philippe Rosay
James Douglas Armstrong
Original Assignee
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow filed Critical Univ Glasgow
Application granted granted Critical
Publication of ATE288586T1 publication Critical patent/ATE288586T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring Volume Flow (AREA)
AT99955537T 1998-06-06 1999-06-07 Detektierung neuraler aktivität ATE288586T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812127.0A GB9812127D0 (en) 1998-06-06 1998-06-06 Detection of neural activity
PCT/GB1999/001786 WO1999064859A1 (en) 1998-06-06 1999-06-07 Detection of neural activity

Publications (1)

Publication Number Publication Date
ATE288586T1 true ATE288586T1 (de) 2005-02-15

Family

ID=10833277

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99955537T ATE288586T1 (de) 1998-06-06 1999-06-07 Detektierung neuraler aktivität

Country Status (7)

Country Link
US (1) US7038106B1 (de)
EP (1) EP1084406B1 (de)
JP (1) JP4688293B2 (de)
AT (1) ATE288586T1 (de)
DE (1) DE69923556T2 (de)
GB (1) GB9812127D0 (de)
WO (1) WO1999064859A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489535B1 (en) 1999-03-18 2002-12-03 The Board Of Trustees Of The Leland Stanford Junior University Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
DK177327B1 (en) * 2011-12-23 2013-01-14 Entomopharm Aps OPTIMIZED INSECT BASED EX VIVO MODEL FOR EXAMINATION OF BLOOD BRAIN BARRIER penetration and method of exposing the insect brain to chemical compounds
CN103958684A (zh) * 2012-03-19 2014-07-30 瑞健生物医药（苏州）有限公司 氧化还原敏感的钙传感蛋白及其用途方法
CN107636159B (zh) * 2015-02-04 2022-06-14 百时美施贵宝公司 选择治疗性分子的方法
EP3253875B1 (de) 2015-02-04 2020-01-08 H. Hoffnabb-La Roche Ag Tau-antisense-oligomere und verwendungen davon
CN106405029A (zh) * 2016-11-15 2017-02-15 融安县植保植检站 金桔附生绿球藻药剂筛选试验系统
WO2019241319A1 (en) * 2018-06-13 2019-12-19 The Research Foundation For The State University Of New York Chromatic bioluminescence as a cellular level readout system of neural activity
JP2022538231A (ja) * 2019-06-25 2022-09-01 モレキュラー デバイシーズ， エルエルシー 生物学的細胞からの振動蛍光の分析

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015184A1 (en) * 1992-01-24 1993-08-05 Yale University Assay for neuro-excitatory agents
US5714666A (en) 1993-02-09 1998-02-03 Children's Hospital Of Philadelphia Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells
FR2727017B1 (fr) * 1994-11-21 1996-12-20 Sophie Feldblum Procede de criblage de facteurs sur modele de paralysie et methode d'obtention de ce modele
US5777195A (en) 1996-05-17 1998-07-07 The Rockefeller University Knockout mutant mouse for DARPP-32 and use thereof

Also Published As

Publication number Publication date
EP1084406B1 (de) 2005-02-02
DE69923556D1 (de) 2005-03-10
WO1999064859A1 (en) 1999-12-16
EP1084406A1 (de) 2001-03-21
US7038106B1 (en) 2006-05-02
JP2002517754A (ja) 2002-06-18
DE69923556T2 (de) 2006-01-26
GB9812127D0 (en) 1998-08-05
JP4688293B2 (ja) 2011-05-25

Similar Documents

Publication Publication Date Title
CA2175326A1 (en) Method for Determining Parameter of Hydrocarbon
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DZ3147A1 (fr) Méthode de surveillance sismique d'une zone souterraine par utilisation simultanée de plusieurs sources vibrosismiques.
BR9607193B1 (pt) teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos.
WO2003008647A3 (en) Blood assessment of injury
CA2266730A1 (en) Method and system for monitoring animals
ATE275869T1 (de) Überprüfung der unversehrtheit eines normalen standardmusters
WO2001093748A3 (en) Relative nerve movement and status detection system and method
WO2003027636A3 (en) Urine detection system and method
DE69936152D1 (de) System und verfahren zur dynamischen korrelation von ereignissen
DE69637100D1 (de) Kostengünstige elektroden für eine iontophoretische vorrichtung
BR9911194B1 (pt) dispositivo para mediÇço e monitoraÇço de resistividade em um reservatàrio de petràleo em uma formaÇço geolàgica, e, processo para mediÇço de resistividade em um reservatàrio de petràleo em uma formaÇço geolàgica.
WO2003036031A3 (en) Seismic monitoring of in situ conversion in a hydrocarbon containing formation
FR2697101B1 (fr) Procédé de détection de la parole.
ATE288586T1 (de) Detektierung neuraler aktivität
WO1999027463A3 (de) Verfahren zur bestimmung wenigstens einer diagnostischen information aus signalmustern medizinischer sensorsysteme
DE69603681D1 (de) Verwendung mindestens eines beta-adrenergen Agonisten als Antagonist der Substanz P
DE69030469D1 (de) Zylinderbüchseneinsatz und Verfahren, damit einen Motorblock herzustellen
BR9908795B1 (pt) sensor eletroquìmico para medir a atividade de um componente metálico e método para a produção de um sensor eletroquìmico.
DE60038894D1 (de) Screeningverfahren für geeignete wirkstoffe
WO2003081253A3 (en) Electrochemical multi-well plate
DE68914617D1 (de) Nachweisvorrichtung für Kathodenlumineszenzanalyse.
EA200200435A1 (ru) Анализ лептина
ATE392619T1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
FR2787199B1 (fr) Procede de detection, notamment de petites cibles marines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties